pharmexec.com
/1 week ago
Latest updates for Top Pharma Strategy
Fresh curated links around Top Pharma Strategy are collected here so marketers can spot useful updates and turn timely ideas into posts faster.
Recent items include:
- <![CDATA[How Pharma is Adjusting Strategies for Changing Dynamics at FDA]]>
- <![CDATA[Rethinking Pharma's Go-to-Market Formula]]>
- <![CDATA[Alternative Supply Chain Strategies Companies Should Prioritize]]>
Post angles to try
Share the most useful takeaway for your audience.
Turn one article into a quick practical checklist.
Ask your audience how this shift affects their work.
Fresh articles and ideas
Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.
pharmexec.com
/4 weeks ago
<![CDATA[Alternative Supply Chain Strategies Companies Should Prioritize]]>
pharmexec.com
/1 month ago
<![CDATA[Pfizer at a Crossroads: Leadership, Strategy, and the Risk of a Narrative Cliff]]>
pharmexec.com
/2 weeks ago
<![CDATA[Beyond the Molecule: The New Competitive Battlefield in Oncology]]>
pharmexec.com
/1 month ago
<![CDATA[Asembia ASX26: Strategies for Building Relationships with Pharma Manufacturers]]>
seekingalpha.com
/1 month ago
Astellas Pharma Inc. (ALPMY) Discusses R&D Strategy and Focus Areas in Innovative Healthcare - Slideshow
pharmexec.com
/2 weeks ago
<![CDATA[Optimizing Biopharma Commercial Strategy and Patient Support Programs: Q&A with Dean Erhardt]]>
pharmexec.com
/1 month ago
<![CDATA[Your Hub Strategy Is Our Strategy: Understanding Patient Support Programs That Adapt, Scale, and Deliver]]&g...
pharmexec.com
/1 month ago
<![CDATA[Asembia ASX26: Adjusting Strategies to Adapt to an Uncertain Global Political and Regulatory Market]]>
pharmexec.com
/2 weeks ago
<![CDATA[Adjusting Strategies Over a 25-Year-Long Career]]>
pharmexec.com
/1 week ago
<![CDATA[The Implications of GLP-1s Replacing Oncology as the Key Value Driver]]>
pharmexec.com
/1 month ago
<![CDATA[The New Era of U.S. Pharmaceutical Pricing: From Policy Upheaval to Strategic Adaptation]]>
pharmexec.com
/2 weeks ago
<![CDATA[Why 75 Top Pharma Execs Are Ditching Fragmented Marketing Stacks]]>
pharmexec.com
/2 weeks ago
<![CDATA[Global leader in engagement with healthcare stakeholders]]>
pharmexec.com
/1 week ago
<![CDATA[What Pharma Investors Should Expect in the Current Regulatory Environment]]>
pharmexec.com
/1 month ago
<![CDATA[New Federal Market Access Restrictions: Optimizing Manufacturer Strategies as PBMs Gain Power]]>
pharmexec.com
/2 weeks ago
<![CDATA[The Insight Gap: Biopharma’s Hidden Risk in the Race Against the Patent Cliff]]>
pharmexec.com
/2 weeks ago
<![CDATA[Developing New Therapies Across Multiple Regulatory Landscapes]]>
pharmexec.com
/1 week ago
<![CDATA[What's Driving the Concentration of Blockbuster Drugs]]>
labiotech.eu
/2 weeks ago
Inside CSL’s strategy to simplify a biotech giant
Delve into the Australian biotech giant CSL's strategy to refocus a company built on complex modalities. The post Inside CSL’s strategy to simplify a biotech giant appeared first...
fiercebiotech.com
/1 month ago
Which blockbuster is GSK gunning for next? CEO Miels is looking to oncology
When it comes to GSK’s new dealmaking strategy of trying to outdo established blockbusters, CEO Luke Miels has told Fierce that oncology may offer the most tempting targets.
pharmexec.com
/1 month ago
<![CDATA[Pharma Finance Roundup: Platform Innovation Drives Biotech Investment Across Oncology and Immunology]]>
Turn fresh research into a full content calendar
Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.
Sources covering Top Pharma Strategy
seekingalpha.com
Recent coverage from public sources
Public source
fiercebiotech.com
Recent coverage from public sources
Public source
labiotech.eu
Recent coverage from public sources
Public source
pharmexec.com
Recent coverage from public sources
Public source